Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Advanced Oncotherapy PLC       GB00B16JQ761

ADVANCED ONCOTHERAPY PLC

SummaryNewsCalendarCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Advanced Oncotherapy : Early evidence for use of protons in Hodgkin Lymphoma

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/14/2014 | 01:37am EDT

A recent study carried out at the University of Florida Proton Therapy Institute concluded that proton therapy following chemotherapy has a success rate similar to conventional treatments for Hodgkin Lymphoma. It also concluded that proton therapy is a much safer alternative as it does not result in latter effects of conventional radiotherapy like breast cancer and heart disease.


The study tracked 15 patients from September 2009 until June 2013. This study supports the use of proton therapy for positive long-term treatment outcomes and reduced damage to the surrounding tissue. These are early stage results but emphasis the potential of proton therapy to treat not only children and head/neck tumors but complicated later stage cancers like Hodgkin's disease.


Related Article

[Read More...]
International Journal of Radiation Oncology, Biology and Physics

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ADVANCED ONCOTHERAPY PLC
08/07ADVANCED ONCOTHERAPY : Issue of equity and new debt facility
PU
06/03ADVANCED ONCOTHERAPY : Technological update
PU
04/16ADVANCED ONCOTHERAPY : Senior Management Appointment
PU
2018ADVANCED ONCOTHERAPY : Launch of 2018 SAYE Scheme
PU
2018RAYSEARCH LABORATORIES PUBL : expands product line-up with a treatment control s..
AQ
2018ADVANCED ONCOTHERAPY : GPSL Research - Flash Note on AVO
PU
2018ADVANCED ONCOTHERAPY : Technological update
PU
2018ADVANCED ONCOTHERAPY : GPSL Research - Flash Note on AVO
PU
2018ADVANCED ONCOTHERAPY : Technological update
PU
2018ADVANCED ONCOTHERAPY : New proton beam cancer therapy brought to uk
AQ
More news
Chart ADVANCED ONCOTHERAPY PLC
Duration : Period :
Advanced Oncotherapy PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Nicolas Serandour Chief Executive Officer & Director
Michael Jeffrey Sinclair Executive Chairman
Ed Lee Chief Operating Officer
Graham Pughe Senior Vice President-Accounting & IT
Manuel Gallas Director-Technology & Engineering
Sector and Competitors
1st jan.Capitalization (M$)
ADVANCED ONCOTHERAPY PLC108
THERMO FISHER SCIENTIFIC22.13%109 454
DANAHER CORPORATION33.04%98 416
BOSTON SCIENTIFIC CORPORATION18.48%58 324
INTUITIVE SURGICAL3.45%57 612
EDWARDS LIFESCIENCES CORPORATION40.50%44 757